Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.

Jin YZ, Thompson BD, Zhou ZY, Fu Y, Birnbaumer L, Wu MX.

Eur J Immunol. 2008 Jul;38(7):1988-98. doi: 10.1002/eji.200737738.

2.

FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus.

Zhi L, Kim P, Thompson BD, Pitsillides C, Bankovich AJ, Yun SH, Lin CP, Cyster JG, Wu MX.

J Immunol. 2011 Sep 1;187(5):2244-51. doi: 10.4049/jimmunol.1100670. Epub 2011 Jul 25.

3.

Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Green DS, Center DM, Cruikshank WW.

J Virol. 2009 Jun;83(11):5765-72. doi: 10.1128/JVI.00130-09. Epub 2009 Mar 18.

5.

Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.

Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C.

J Immunol. 2006 Jun 15;176(12):7394-401.

6.

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, Blazar BR.

Blood. 2005 Apr 15;105(8):3372-80. Epub 2004 Dec 23.

7.

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.

Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS.

J Immunol. 2004 Jul 15;173(2):845-54.

8.

Migration and activation of T cells during development of graft-versus-host disease in a mouse model.

Wen HS, Wang JM, Zhou H, Gong SI, Gao L, Wu Y.

Transplant Proc. 2013 Mar;45(2):713-8. doi: 10.1016/j.transproceed.2012.12.004.

PMID:
23498811
9.

Requirement of Galphai in thymic homing and early T cell development.

Jin Y, Wu MX.

Mol Immunol. 2008 Jul;45(12):3401-10. doi: 10.1016/j.molimm.2008.04.007. Epub 2008 May 23.

10.

PI3Kγ controls leukocyte recruitment, tissue injury, and lethality in a model of graft-versus-host disease in mice.

Castor MG, Rezende BM, Bernardes PT, Vieira AT, Vieira EL, Arantes RM, Souza DG, Silva TA, Teixeira MM, Pinho V.

J Leukoc Biol. 2011 Jun;89(6):955-64. doi: 10.1189/jlb.0810464. Epub 2011 Mar 14.

PMID:
21402770
11.

An essential role for RGS protein/Gαi2 interactions in B lymphocyte-directed cell migration and trafficking.

Hwang IY, Park C, Harrison K, Boularan C, Galés C, Kehrl JH.

J Immunol. 2015 Mar 1;194(5):2128-39. doi: 10.4049/jimmunol.1401952. Epub 2015 Jan 23.

12.

TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunit.

Huang TT, Zong Y, Dalwadi H, Chung C, Miceli MC, Spicher K, Birnbaumer L, Braun J, Aranda R.

Int Immunol. 2003 Nov;15(11):1359-67.

PMID:
14565934
13.

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.

Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A, Giannola D, Emerson SG.

J Immunol. 2002 Dec 15;169(12):7111-8.

14.

T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.

Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, Lira SA, Cook DN, Blazar BR.

Blood. 2000 Nov 1;96(9):2973-80.

15.

The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.

Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, Arantes RM, Souza DG, Silva TA, Proudfoot AE, Teixeira MM, Pinho V.

J Immunol. 2010 Mar 1;184(5):2646-54. doi: 10.4049/jimmunol.0902614. Epub 2010 Jan 25.

16.

T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.

Sandy AR, Chung J, Toubai T, Shan GT, Tran IT, Friedman A, Blackwell TS, Reddy P, King PD, Maillard I.

J Immunol. 2013 Jun 1;190(11):5818-28. doi: 10.4049/jimmunol.1203452. Epub 2013 May 1.

17.

Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?

Vianello F, Cannella L, Coe D, Chai JG, Golshayan D, Marelli-Berg FM, Dazzi F.

Br J Haematol. 2013 Sep;162(6):808-18. doi: 10.1111/bjh.12472. Epub 2013 Jul 15.

PMID:
23855835
18.

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA.

J Immunol. 2000 Nov 1;165(9):4901-9.

19.

Regulatory role of host CD8+ T lymphocytes in experimental graft-versus-host disease across a single major histocompatibility complex class II incompatibility.

de Lavareille A, Prigogine C, Paulart F, Nagy N, Habran C, Haddou NO, Le Moine A, Salmon I, Goldman M, Flamand V.

Transplantation. 2005 Nov 15;80(9):1293-9.

PMID:
16314798
20.

Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury.

Köhler D, Devanathan V, Bernardo de Oliveira Franz C, Eldh T, Novakovic A, Roth JM, Granja T, Birnbaumer L, Rosenberger P, Beer-Hammer S, Nürnberg B.

PLoS One. 2014 May 23;9(5):e98325. doi: 10.1371/journal.pone.0098325. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0119092.

Supplemental Content

Support Center